In 2019, Parkinson's disease incurred a social and healthcare cost of nearly €22.8 billion in Europe, with a forecast of reaching €28.8 billion by 2025. The prevalence of this neurodegenerative disease has nearly doubled since 1990, exacerbated by the aging population. Healthcare systems are increasingly under pressure as the number of affected individuals continues to rise.